ACUTE LYMPHOBLASTIC LEUKEMIA ALL
Clinical trials for ACUTE LYMPHOBLASTIC LEUKEMIA ALL explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKEMIA ALL trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKEMIA ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lab-Made donor cells aim to beat cancer without the side effects
Disease control OngoingThis study is for children and young adults up to age 21 with high-risk blood cancers like leukemia or lymphoma. It tests a transplant using specially treated donor cells from a family member to reduce the risk of the cancer coming back while lowering the chance of a serious side…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA ALL
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 17, 2026 02:38 UTC
-
New hope for tough leukemia: drug cocktail targets relapsed cases
Disease control OngoingThis early-phase study tests a combination of three drugs—ribociclib, everolimus, and dexamethasone—in children and young adults (ages 1 to 30) whose acute lymphoblastic leukemia (ALL) has returned or not responded to standard treatments. The main goals are to find the safest dos…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA ALL
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 13, 2026 16:01 UTC